BioArray Q&A: Clinical Microarrays Gears Up for Protein Biomarker Platform Launch | GenomeWeb

Natick, Mass.-based Clinical Microarrays announced recently that it had received Series A funding of $7.5 million from investors including Oxford Bioscience Partners, Rock Maple Ventures, Fletcher Spaght Venture Partners, and a group of individual investors led by the firm’s chairman, Jean “Coco” Montagu, a former vice president of advanced technology at Affymetrix, who had provided seed funding for the company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.